Further studies highlighted that FoA intake reduced HOMA-IR and improved endothelial dysfunction in individuals with MetS and that it was beneficial for glycemic markers, including Fasting Blood Glucose (FBG) and fasting insulin [75]. Here, INS is linked to metabolic syndrome.